Kelun Biotech presents oncology study data at ESMO Congress
October 15, 2026 | 16:43
Biopharmaceutical firm Sichuan Kelun-Biotech scheduled multiple research presentations detailing its oncology drug development pipeline at the European Society for Medical Oncology Congress in Madrid.
Mobile Version